Diminished expression of surface CD5 (sCD5) is associated with several pathological conditions, including systemic lupus erythematosus [19], multiple sclerosis [20], B-cell chronic lymphocytic leukemia [21], and T-cell acute lymphoblastic leukemia (T-ALL) [22]. This evidence concerns the gene SCD5 and T-cell acute lymphoblastic leukemia.